Vijay Iyengar
Vermogen: 4 M $ op 31-05-2026
Vermogen: 4 M $ op 31-05-2026
Vijay Iyengar is currently President at HistoRx, Inc. Former positions include EVP, Head-Global Medical Affairs & Product at Incyte Corp.
from 2016 to 2025; President at Genoptix, Inc. from 2014 to 2016; Vice President & Head-Rare Disease at Novartis Oncology, Inc. from 2011 to 2014; Vice President & General Manager at Novartis Hellas SACI from 2009 to 2011; Executive Director-Global Brand at Novartis Pharmaceuticals Corp.
from 2007 to 2009; and Engagement Manager at McKinsey & Co., Inc. Education includes undergraduate studies at Stanford University and a doctorate from Harvard Medical School.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
INCYTE CORPORATION 0,02% | 16-07-2025 | 40.540 ( 0,02% ) | 4 M $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
HistoRx, Inc.
HistoRx, Inc. Medical SpecialtiesHealth Technology Develops tissue-based diagnostic products | President | - |
| Bedrijven | Functie | Einde |
|---|---|---|
| INCYTE CORPORATION | Corporate Officer/Principal | 31-12-2025 |
Genoptix, Inc.
Genoptix, Inc. Medical SpecialtiesHealth Technology Provides personalized medicine services | President | 01-04-2016 |
Novartis Oncology, Inc.
Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Corporate Officer/Principal | 01-03-2014 |
Novartis Hellas SACI
Novartis Hellas SACI Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products to improve and extend people's lives | Corporate Officer/Principal | 01-12-2011 |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Corporate Officer/Principal | 01-06-2009 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 9 |
|---|---|
Incyte Corp.
Incyte Corp. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of proprietary therapeutics | Health Technology |
Novartis Oncology, Inc.
Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Genoptix, Inc.
Genoptix, Inc. Medical SpecialtiesHealth Technology Provides personalized medicine services | Health Technology |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
HistoRx, Inc.
HistoRx, Inc. Medical SpecialtiesHealth Technology Develops tissue-based diagnostic products | Health Technology |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Hellas SACI
Novartis Hellas SACI Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products to improve and extend people's lives | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau